Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02779231 · ClinicalTrials.gov registry record · NA

Text Messages and Blood Pressure Control

A NA study, sponsored by Linnea Polgreen.

Completed
Registry status
NA
Development phase
430
Enrollment target

NCT02779231: Completed NA study, sponsored by Linnea Polgreen.

NCT02779231 is a NA study that has completed, run by Linnea Polgreen. The registered enrollment target is 430 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02779231, a NA study, has completed, sponsored by Linnea Polgreen.

COMPLETED
Registry status
NA
Development phase
430 participants
Enrollment target

Study Summary

Hypertension remains one of the most important preventable contributors to disease and death. It is the most common risk factor for strokes and myocardial infarctions in the U.S., and is associated with the greatest attributable risk for mortality among all modifiable risk factors for cardiovascular events. Over 50 million people are living with hypertension in the United States, and hypertension is one of the most common reasons for visits to a healthcare provider. Abundant evidence from randomized controlled trials has shown benefit of antihypertensive drug treatment in reducing important health outcomes in persons with hypertension. Yet, approximately 20% of U.S. adults are unaware that they have the disease. Hypertension is more difficult to diagnose than other common medical illnesses. In most cases, hypertension is asymptomatic; and accordingly patients do not seek care for it as they do for other common symptomatic illness. Patients are frequently diagnosed after presenting with end organ disease (e.g., myocardial infarctions, congestive heart failure, strokes, or renal failure). Another complicating aspect related to diagnosing uncontrolled hypertension is that multiple blood pressure measurements are needed to establish a diagnosis. Blood pressure readings can be falsely elevated in clinic due to the presence of an observer or the clinical surrounding (e.g., white coat hypertension). Even if an elevated blood pressure reading is identified in a clinic setting, more readings are needed in order to make it possible for physicians to decide about the next appropriate medical intervention. This need for multiple BP measurements over time often delays both initiating and modifying medical therapy for uncontrolled hypertension. Having patients take their BP at home facilitates the more timely diagnosis of uncontrolled hypertension by reducing diagnostic uncertainty. In fact, home measurements are better diagnostic indicators of stroke and cardiovascular mortali

Primary Outcome

The number of participants who completed the home blood pressure assignment will be compared between the two groups. These data will be extracted from the medical records for the standard of care group and from the "texting" website for the texting group.

Interventions

  • OTHER Bi-directional texting

Trial Details

FieldValue
Enrollment Target 430 participants
Start Date 2015-09
Est. Completion 2017-09-30
Phase NA
Linnea Polgreen

4 total trials

What the finished NCT02779231 record still lists

NCT02779231 is an interventional study that assigns participants to a tested intervention. The registered 430 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).

The record links to 0 conditions, and to 1 intervention - of which Bi-directional texting is the first listed.

NCT02779231 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02779231 about?

NCT02779231 is a clinical study titled "Text Messages and Blood Pressure Control". Hypertension remains one of the most important preventable contributors to disease and death. It is the most common risk factor for strokes and myocardial infarctions in the U.S., and is associated with the greatest attributable risk for mortality among all modifiable risk factors for cardiovascular...

What is the current status of trial NCT02779231?

This trial is currently completed. It is a NA study. The enrollment target is 430 participants. The study started on 2015-09. Estimated completion is 2017-09-30.

What interventions are being tested in trial NCT02779231?

The interventions under investigation include: Bi-directional texting (OTHER).

Who is sponsoring clinical trial NCT02779231?

This trial is sponsored by Linnea Polgreen, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02779231's enrollment target sits among peer trials

430 235th of 2000 higher than 1,765 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05327023 · 430 participants · Phase 1

    Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

  • NCT05457985 · 430 participants · NA

    Testing Adaptive Interventions to Improve Posttraumatic Stress Disorder Treatment Outcomes in Federally Qualified Health Centers

  • NCT05532982 · 430 participants

    Parkinson's Disease in Asian Americans

  • NCT05844891 · 430 participants · NA

    Telehealth-Enhanced Asthma Care for Home After the Emergency Room

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02779231, the US trial registry maintained by the National Library of Medicine. NCT02779231 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.